HUMAN PAPILLOMAVIRUS VACCINES AND USES OF THE SAME

USE OF CCL26

TRUNCATED RECOMBINANT L1 PROTEIN OF HUMAN PAPILLOMAVIRUS

IMMORTALIZED CELLS FOR PRODUCTION OF BIOPRODUCTS, METHODS OF PRODUCING BIOPRODUCTS WITH AN IMMORTALIZED CELL, AND METHODS OF MAKING IMMORTALIZED CELLS FOR PRODUCTION OF BIOPRODUCTS

HEPATITIS B VACCINES AND USES OF THE SAME

POLYNUCLEOTIDE MOLECULES USED FOR THE PREVENTION OR TREATMENT OF HPV INFECTION RELATED DISEASES

ENGINEERED DNA MOLECULE FOR CODING RNA

NON-INTEGRATING VIRAL DELIVERY SYSTEM AND METHODS RELATED THERETO

CHIMERIC PAPILLOMAVIRUS L1 PROTEIN

CHIMERIC PAPILLOMAVIRUS L1 PROTEIN

CHIMERIC PAPILLOMAVIRUS L1 PROTEIN

CHIMERIC PAPILLOMAVIRUS L1 PROTEIN

CHIMERIC PAPILLOMAVIRUS L1 PROTEIN

CHIMERIC PAPILLOMAVIRUS L1 PROTEIN

CHIMERIC PAPILLOMAVIRUS L1 PROTEIN

CHIMERIC PAPILLOMAVIRUS L1 PROTEIN

CHIMERIC PAPILLOMAVIRUS L1 PROTEIN

CHIMERIC PAPILLOMAVIRUS L1 PROTEIN

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DEMYELINATING DISEASES CONTAINING SUPERNATANT OF IMMORTALIZED MESENCHYMAL STEM CELLS, AND PHARMACEUTICAL PREPARATION CONTAINING SAME COMPOSITION AS ACTIVE INGREDIENT

CHIMERIC PAPILLOMAVIRUS L1 PROTEIN

THERAPEUTIC PAPILLOMA VIRUS VACCINES

USE OF CCL13

NON-INTEGRATING VIRAL DELIVERY SYSTEM AND METHODS RELATED THERETO

CMV-BASED HUMAN PAPILLOMAVIRUS VACCINES

ESTABLISHMENT OF ERYTHROID PRECURSOR CELL LINE CAPABLE OF CONDITIONAL MATURATION USING GENE OVEREXPRESSION

LENTIVIRAL VECTOR FOR EXPRESSION OF HUMAN PAPILLOMAVIRUS (HPV) ANTIGENS AND ITS IMPLEMENTATION IN THE TREATMENT OF HPV INDUCED CANCERS

COMBINATION THERAPIES AGAINST CANCER AND INFECTIOUS DISEASES

NOVEL ADENOVIRUS VACCINE THERAPY FOR THE TREATMENT OF RECURRENT RESPIRATORY PAPILLOMATOSIS

Methods for providing purified viral particles of Semliki Forest Virus (SFV), preparations obtainable thereby, and uses thereof

Cell-Penetrating Peptides and Methods of Use Thereof

Polynucleotide molecules used for the prevention or treatment of HPV infection related diseases

HUMAN PAPILLOMAVIRUS TYPE 18 CHIMERIC PROTEIN AND USE THEREOF

VIRUS-INSPIRED COMPOSITIONS AND METHODS OF REDIRECTING PREEXISTING IMMUNE RESPONSES USING THE SAME FOR TREATMENT OF CANCER

COMPOSITIONS AND METHODS FOR ISOLATING T CELL RECEPTORS (TCRS) AND CELLS EXPRESSING THE SAME

GLYCOPROTEIN D VARIANTS AS VACCINE ADJUVANTS

ARENAVIRUSES AS VECTORS

LIMITED SELF-REPLICATING MRNA MOLECULAR SYSTEM, PRODUCING METHOD AND USE

Human Papilloma Virus Vaccines and Uses of the Same for HPV Associated Diseases

T CELL-DIRECTED ANTI-CANCER VACCINES AGAINST COMMENSAL VIRUSES FOR TREATING MUCOSAL CARCINOMAS

VACCINE FORMULATION COMPRISING RECOMBINANT OVERLAPPING PEPTIDES AND NATIVE PROTEINS

MODIFIED HUMAN PAPILLOMAVIRUS TYPE 52 L1 PROTEIN AND USE THEREOF

CONJUGATED VIRUS-LIKE PARTICLES AND USES THEREOF AS ANTI-TUMOR IMMUNE REDIRECTORS

PROCESS FOR PRODUCING A PROPHYLACTIC AND THERAPEUTIC DNA IMMUNOLOGICAL COMPOSITION FOR HPV AND CANCERS ASSOCIATED WITH THE VIRUS, HYBRID PROTEIN, EXPRESSION VECTOR, IMMUNOLOGICAL COMPOSITION AND USES THEREOF

Hepatitis B vaccines and uses of the same

HETEROLOGOUS COMBINATION PRIME:BOOST THERAPY AND METHODS OF TREATMENT

Recombinant P5 Promoter for Use in Reducing DNA Contamination of AAV Preparations

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

STRUCTURALLY MODIFIED CHIMERIC POLYPEPTIDE OF HUMAN PAPILLOMAVIRUS, RECOMBINANT PROTEIN COMPRISING SAME POLYPEPTIDE, AND USE OF SAME PROTEIN

TREATMENT OF HPV-RELATED DISEASES

Compositions, Methods and Systems for the Delivery of Gene Editing Material to Cells

Chimeric papilloma virus L1 protein

CELL CAPABLE OF ACTIVATING IMMUNE SYSTEM, AND PHARMACEUTICAL COMPOSITION CONTAINING SAID CELL

HPV vaccine

Virus-inspired compositions and methods of redirecting preexisting immune responses using the same for treatment of cancer

Method of detecting new immunogenic T cell epitopes and isolating new antigen-specific T cell receptors by means of an MHC cell library

Mutant of L1 protein of human papillomavirus type 18

Cell-penetrating peptides and methods of use thereof

Detection of nucleic acids from multiple types of human papillomavirus

Vaccines for human papilloma virus and methods for using the same

INHIBITION OF INNATE IMMUNE RESPONSE

HETEROLOGOUS COMBINATION PRIME:BOOST THERAPY AND METHODS OF TREATMENT

HUMAN PAPILLOMAVIRUS VACCINES AND USES OF THE SAME

Hepatitis B vaccines and uses of the same

Detection of nucleic acids from multiple types of human papillomavirus

Serologic test for therapy control of HPV16 positive carcinoma

Non-human papillomaviruses for gene delivery in vitro and in vivo

ANTI-CANCER DNA VACCINE EMPLOYING PLASMIDS ENCODING SIGNAL SEQUENCE, MUTANT ONCOPROTEIN ANTIGEN, AND HEAT SHOCK PROTEIN

HPV vaccine

Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors

HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines

Mutant of L1 protein of human papillomavirus type 58

Detection of nucleic acids from multiple types of human papillomavirus

Compositions and methods of treatment

Compositions, methods and uses for improved human papilloma virus constructs

Virus-like particle compositions and vaccines against epstein-barr virus infection and disease

Detection of nucleic acids from multiple types of human papillomavirus

Transmembrane nanopore with nucleic acid unwinding function and its construction methods and applications

Detection of nucleic acids from multiple types of human papillomavirus

Non-integrating viral delivery system and methods related thereto

Vaccines for human papilloma virus and methods for using the same

HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines

HPV particles and uses thereof

Immunomodulating composition for treatment

L2 peptide immunogenicity

Serologic test for therapy control of HPV16 positive carcinoma

Mutant of L1 protein of human papillomavirus type 11

Papillomavirus chimeric protein and application thereof

Virus like particle with efficient epitope display

Immortalized stem cells and method for producing same

Separation of human papillomavirus nucleic acids from biological samples

Dps fusion proteins for use in vaccines and diagnostics

Inhibition of innate immune response

POLYNUCLEOTIDES FOR TREATING ONCOGENIC VIRAL POLYPEPTIDE POSITIVE TUMORS

Truncated L1 protein of human papillomavirus type 11

Novel Promiscuous HPV16-Derived T Helper Epitopes for Immunotherapy

Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment

HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereof

Virus-like particle compositions and vaccines against Epstein-Barr virus infection and disease

Method of detecting new immunogenic T cell epitopes and isolating new antigen-specific T cell receptors by means of an MHC cell library

Detection of nucleic acids from multiple types of human papillomavirus

HPV particles and uses thereof

HPV-related fusion protein and applications thereof

HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines

POLYIONIC PAPILLOMA VIRUS-LIKE PARTICLE (VLP) VACCINES

Compositions, methods and uses for improved human papilloma virus constructs

Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses

RECOMBINANT ADENO-ASSOCIATED VIRUS VECTORS CARRYING THE MUTANT HPV- 16 E7 ANTIGEN GENE, CONSTRUCTION METHOD AND APPLICATION THEREOF

CyaA-based chimeric proteins comprising a heterologous polypeptide and their uses in the induction of immune responses

METHODS AND COMPOSITIONS FOR INCREASING A T-EFFECTOR CELL TO REGULATORY T CELL RATIO

Truncated L1 protein of human papillomavirus type 11

Adenoviral vector vaccine

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

Polynucleotides for treating oncogenic viral polypeptide positive tumors

PLASMIDS AND METHODS FOR PEPTIDE DISPLAY AND AFFINITY-SELECTION ON VIRUS-LIKE PARTICLES OF RNA BACTERIOPHAGES

Immunity enhancing therapeutic vaccine for HPV and related diseases

Promiscuous HPV16-derived T helper epitopes for immunotherapy

IMMUNOGENIC POLYPEPTIDES COMPRISING A SCAFFOLD POLYPEPTIDE AND A L2 POLYPEPTIDE OR A FRAGMENT THEREOF

Human Papilloma virus therapeutic vaccine

Recombinant protein bodies as immunogen-specific adjuvants

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

Method of efficient extraction of protein from cells

Truncated L1 protein of human papillomavirus type 58

Fine epitope peptide capable of inducing cross-reactive antibodies among homologous proteins in human papilloma virus E6 protein

Dps fusion proteins for use in vaccines and diagnostics

Vaccine combinations

Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses

Baculovirus system for expressing proteins forming virus-like particles

Vaccines against HPV

Detection of nucleic acids from multiple types of human papillomavirus

Detection of nucleic acids from multiple types of human papillomavirus

Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response

HPV/CyaA-based chimeric proteins and their uses in the induction of immune responses against HPV infection and HPV-induced disorders

Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancer

HPV E6 PROTEIN T CELL EPITOPES AND USES THEREOF

Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment

CyaA-based chimeric proteins comprising a heterologous polypeptide and their uses in the induction of immune responses

Compositions and uses therefor

Deletion mutants of flagellin and methods of use

Deletion mutants of flagellin and methods of use

HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines

VACCINES AGAINST HPV

Polynucleotides for treating oncogenic viral polypeptide positive tumors

HPV chimaeric particle

Compositions and reaction mixtures for the detection of nucleic acids from multiple types of human papillomavirus

Genes encoding major capsid protein L1 of human papilloma virus

Truncated L1 protein of human papillomavirus type 6

Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof

Inhibition of innate immune response

Method for enhancing the production yield of human papillomavirus L1 protein

Truncated L1 protein of human papillomavirus type 33

Adenoviral expression vector encoding a CD40L fusion protein

Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use

Polyionic papilloma virus-like particle (VLP) vaccines

Compositions, reaction mixtures and methods for detecting nucleic acids from multiple types of human papillomavirus

Human erythroid progenitor cell line comprising HPV E6/E7 operably linked to an inducible promoter and method for producing human enucleated red blood cells

Compositions, reaction mixtures and methods for detecting nucleic acids from multiple types of human papillomavirus

Peptide scaffold design

Truncated L1 protein of human papillomavirus type 58

Truncated L1 protein of human papillomavirus type 52

Minimal motifs of linear B-cell epitopes in L1 protein from human papillomavirus type 58 and their applications

Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancer

Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies

DPS fusion proteins for use in vaccines and diagnostics

Agent for use in the topical or local treatment of cervical dysplasias

Inducing Cellular Immune Responses to Human Papillomavirus Using Peptide and Nucleic Acid Compositions

Plasmids and methods for peptide display and affinity-selection on virus-like particles of RNA bacteriophages

Methods of generating immune responses with compositions comprising an adenoviral expression vector comprising a CD40L fusion protein

Vaccines for the treatment of neoplasias from viral capsids of birnavirus containing antigens of the human papillomavirus

Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen

Compositions and Methods for Enhancing Antigen-Specific Immune Responses

Therapeutic Compositions For The Treatment of HPV-Induced Diseases

METHODS FOR ENHANCING ANTIGEN-SPECIFIC IMMUNE RESPONSES

Mammalian cell lines for increasing longevity and protein yield from a cell culture

Composition comprising an adenoviral expression vector comprising a CD40L fusion protein for generating immune responses

HPV particles and uses thereof

METHOD OF PREPARATION OF A BIOLOGICAL PARTICULATE STRUCTURE

Tat-Based Vaccine Compositions and Methods of Making and Using Same

Lipidated polyepitope vaccines

Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use

Mammalian cell lines for increasing longevity and protein yield from a cell culture

NOVEL COMPOSITIONS

THERAPEUTIC AND PROPHYLACTIC VACCINE FOR THE TREATMENT AND PREVENTION OF PAPILLOMAVIRUS INFECTION

Vaccines for human papilloma virus and methods for using the same

Dry Powder Formulations, Vaccines and Methods

CONSTRUCT SYSTEM AND USES THEREFOR

Molecule

Detection of nucleic acids from multiple types of human papillomaviruses

HPV E6 protein T cell epitopes and uses thereof

Immunogenic polypeptides comprising a scaffold polypeptide and a L2 polypeptide or a fragment thereof

Recombinant Protein Bodies as Immunogen-Specific Adjuvants

Genes encoding major capsid protein L1 of human papilloma virus

Multi-component L2 vaccine for prevention of human papilloma virus infection

Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant

SYNTHETIC VIRUS-LIKE PARTICLES CONJUGATED TO HUMAN PAPILLOMAVIRUS CAPSID PEPTIDES FOR USE AS VACCINES

Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof

COMPOSITIONS AND METHODS FOR TREATING HUMAN PAPILLOMAVIRUS-MEDIATED DISEASE

BIOACTIVE PURIFIED HSPE7 COMPOSITIONS

Deletion mutants of flagellin and methods of use

METHODS OF LONG-TERM CULTURE OF EUKARYOTIC CELLS AND USES THEREOF

MAGE-A3/HPV 16 PEPTIDE VACCINES FOR HEAD AND NECK CANCER

Combination of protein vaccine and mesenchymal stem cells for treating cancer

Expression system for modulating an immune response

Papilloma Virus-Like Particles, Fusion Proteins as Well as Processes for Their Production

METHODS AND MEANS FOR THE TREATMENT OF HPV INDUCED INTRAEPITHELIAL NEOPLASIAS

Anticancer Combination Therapies

Lipidated tumor-associated antigens and immunotherapeutic compositions

DIAGNOSING AND PROTECTING HORSES AGAINST PAPILLOMAVIRUS

Mammalian cell lines for increasing longevity and protein yield from a cell culture

COMPOSITIONS OF TOLL-LIKE RECEPTOR AGONISTS AND PAPILLOMAVIRUS ANTIGENS AND METHODS OF USE THEREOF

Vectors for multiple gene expression

Multitype HPV peptide compositions and methods for treatment or prevention of human papillomavirus infection

Truncated L1 protein of human papillomavirus type 11

DNA vaccine for treating or preventing cervical cancer comprising a gene encoding HPV protein

Compounds and methods associated with differential methylation of human papilloma virus genomes in epithelial cells

Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein

Truncated L1 protein of human papillomavirus type 18

HPV polyepitope constructs and uses thereof

Optimized expression of HPV 58 L1 in yeast

RESPIRATORY SYNCYTIAL VIRUS VACCINE BASED ON CHIMERIC PAPILLOMAVIRUS VIRUS-LIKE PARTICLES OR CAPSOMERES

COMPOSITION AND METHOD FOR TREATING VIRAL INFECTION

Truncated L1 protein of Human Papillomavirus type 16

Truncated L1 protein of human papillomavirus type 6

PLANT-PRODUCED COMPOSITIONS FOR TREATING PAPILLOMAVIRUS INFECTION AND RELATED METHODS

Mixture of Peptides Derived from E6 and/or E7 Papillomavirus Proteins and Uses Thereof

Compositions comprising a B subunit of Shiga toxin and a means stimulating NKT cells

Intradermal HPV peptide vaccination

HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines

Vaccines for human papilloma virus and methods for using the same

Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus

MAGE-A3/HPV 16 PEPTIDE VACCINES FOR HEAD AND NECK CANCER

CHIMERIC PAPILLOMAVIRUS-LIKE PARTICLES

Detection method for human pappilomavirus (HPV) and its application in cervical Cancer

HPV antigen fusion protein vaccine compositions and uses thereof

Detection method for human pappilomavirus (HPV) and its application in cervical cancer

THERAPY OF CANCER BASED ON TARGETING ADAPTIVE, INNATE AND/OR REGULATORY COMPONENT OF THE IMMUNE RESPONSE

Papillomavirus vaccines

Material with immunogenicity

RECOMBINANT VIRAL VACCINE

METHODS AND COMPOSITIONS FOR TREATING CERVICAL CANCER

Detection of nucleic acids from multiple types of human papillomaviruses

Packaging of Immunostimulatory Substances Into Virus-Like Particles: Method of Preparation and Use

Human papillomavirus / Ii-Key hybrids and methods of use

HPV-16-BASED PAPILLOMAVIRUS VACCINES

HPV-18-BASED PAPILLOMAVIRUS VACCINES

Optimized expression of HPV 52 L1 in yeast

HPV vaccine comprising peptides from host cell proteins

Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer

Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment

CD 40 Binding Molecules and CTL Pepetides for Treating Tumors

Mammalian cell lines for increasing longevity and protein yield from cell culture

Papilloma virus vaccine

HPV Vaccine Comprising Peptides From Host Cell Proteins

VACCINE DELIVERY SYSTEM

Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection

Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions

METHODS AND COMPOSITIONS FOR THE PREPARATION AND USE OF TOXIN CONJUGATES

Chimeric papillomavirus-like particles

Virus-Like Particle Containing A Dengue Recombinant Replicon

VACCINE

Capsid proteins and uses therefore

TAT-BASED VACCINE COMPOSITIONS AND METHODS OF MAKING AND USING SAME

Virus-like particle containing a Dengue virus recombinant replicon

Production of packaged DNA sequences

HPV E6 protein T cell epitopes and uses thereof

Method of efficient extraction of protein from cells

Vector for anti-HPV vaccine and transformed microorganism by the vector

Human papilloma virus dominant CD4 T cell epitopes and uses thereof

IMMUNOPEPTIDES OF HPV E6 AND E7 PROTEINS

Advanced cervical cell screening methods

Methods and means for the treatment of HPV induced intraepithelial neoplasia

Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN

Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications

Chimaeric human papillomavirus 16 L1 virus-like particles and a method for preparing the particles

Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies

Antibody inhibiting infection of papillomavirus

TSG101-GAG INTERACTION AND USE THEREOF

Papilloma virus capsomere vaccine formulations and methods of use

Synthetic Protein as Tumor-Specific Vaccine

DIAGNOSING AND PROTECTING HORSES AGAINST PAPILLOMAVIRUS

Peptides for the treatment of cancer associated with the human papilloma virus (HPV) and other epithelial tumors

Detection of nucleic acids from multiple types of human papillomaviruses

PROTEIN CAGE IMMUNOTHERAPEUTICS

MOLECULAR VACCINE LINKING INTERCELLULAR SPREADING PROTEIN TO AN ANTIGEN

Mixture of human papillomavirus virus-like particles

HPV antigens, vaccine compositions, and related methods

Disease Prevention and Vaccination Prior to Thymic Reactivation

Synergistic Effect of Tgf-Beta Blockade and Immunogenic Agents on Tumors

HPV DNA Vaccines and Methods of Use Thereof

POLYEPITOPIC PROTEIN FRAGMENTS OF THE E6 AND E7 PROTEINS OF HPV, THEIR PRODUCTION AND THEIR USE PARTICULARLY IN VACCINATION

Methods and compositions for treating IgE-mediated diseases

Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection

Optimized expression of HPV 52 L1 in yeast

Detection method for human pappilomavirus (HPV) and its application in cervical cancer

Virus-like particles for the induction of autoantibodies

Optimized expression of HPV 31 L1 in yeast

PLANT-PRODUCED COMPOSITIONS FOR TREATING PAPILLOMAVIRUS INFECTION AND RELATED METHODS

Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response

Optimized expression of HPV 45 L1 in yeast

Chimeric papillomavirus-like particles

Anti-cancer DNA Vaccine Employing Plasmids Encoding Mutant Oncoprotein Antigen and Calreticulin